Physician profile
Alvin Jackson
NPI 1346228038
$412.18
in general payments reported to CMS, 2019-2025
12 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.81 · 2021: $73.69 · 2022: $17.99 · 2023: $53.37 · 2024: $52.81 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $63.77 | 2023-2025 | Mounjaro, Zepbound |
| Novartis Pharmaceuticals Corporation | $60.86 | 2021-2023 | |
| Amgen INC. | $50.08 | 2025 | Otezla, Otezla, Repatha |
| Abbott Laboratories | $42.90 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $35.81 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.81 | 2024-2025 | |
| Novo Nordisk INC | $29.20 | 2021-2025 | Wegovy |
| Organon LLC | $27.28 | 2025 | Nexplanon |
| Seqirus USA INC | $22.16 | 2025 | Fluad, Flucelvax |
| Vertex Pharmaceuticals Incorporated | $21.33 | 2025 | |
| Exact Sciences Corporation | $15.79 | 2024 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $13.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alvin Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.